Jim Simons Xtant Medical Holdings, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Xtant Medical Holdings, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 694,208 shares of XTNT stock, worth $256,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares

694,208

Previous 703,810 1.36%

Holding current value

$256,856

Previous $443,000 6.55%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.55 - $0.8 $5,281 - $7,681	-9,602 Reduced 1.36%	694,208 $472,000
Q2 2024 Aug 09, 2024	SELL	$0.63 - $1.03 $37,485 - $61,285	-59,500 Reduced 7.79%	703,810 $443,000
Q1 2024 May 13, 2024	BUY	$0.92 - $1.28 $20,608 - $28,672	22,400 Added 3.02%	763,310 $893,000
Q4 2023 Feb 13, 2024	BUY	$1.04 - $1.39 $74,018 - $98,929	71,172 Added 10.63%	740,910 $837,000
Q3 2023 Nov 14, 2023	BUY	$0.78 - $1.35 $56,727 - $98,182	72,728 Added 12.18%	669,738 $737,000
Q2 2023 Aug 11, 2023	SELL	$0.58 - $0.93 $3,363 - $5,394	-5,800 Reduced 0.96%	597,010 $555,000
Q1 2023 May 12, 2023	SELL	$0.59 - $1.18 $2,065 - $4,130	-3,500 Reduced 0.58%	602,810 $384,000
Q4 2022 Feb 13, 2023	SELL	$0.5 - $0.8 $10,450 - $16,720	-20,900 Reduced 3.33%	606,310 $400,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $0.72 $20,097 - $31,456	-43,690 Reduced 6.51%	627,210 $451,000
Q2 2022 Aug 12, 2022	BUY	$0.47 - $0.7 $2,209 - $3,290	4,700 Added 0.71%	670,900 $349,000
Q1 2022 May 13, 2022	SELL	$0.57 - $0.88 $31,577 - $48,752	-55,400 Reduced 7.68%	666,200 $453,000
Q4 2021 Feb 11, 2022	BUY	$0.56 - $1.26 $22,848 - $51,408	40,800 Added 5.99%	721,600 $404,000
Q3 2021 Nov 12, 2021	SELL	$1.05 - $2.0 $347,760 - $662,400	-331,200 Reduced 32.73%	680,800 $756,000
Q2 2021 Aug 13, 2021	BUY	$1.38 - $2.46 $124,516 - $221,963	90,229 Added 9.79%	1,012,000 $1.65 Million
Q1 2021 May 13, 2021	BUY	$1.23 - $4.33 $361,719 - $1.27 Million	294,081 Added 46.85%	921,771 $2.18 Million
Q4 2020 Feb 10, 2021	BUY	$0.82 - $1.63 $205,821 - $409,133	251,002 Added 66.63%	627,690 $751,000
Q3 2020 Nov 13, 2020	BUY	$0.76 - $1.6 $115,520 - $243,200	152,000 Added 67.65%	376,688 $310,000
Q2 2020 Aug 13, 2020	BUY	$0.62 - $1.74 $84,274 - $236,512	135,927 Added 153.14%	224,688 $202,000
Q1 2020 May 14, 2020	BUY	$0.63 - $1.64 $2,961 - $7,707	4,700 Added 5.59%	88,761 $59,000
Q4 2019 Feb 13, 2020	BUY	$1.55 - $2.89 $5,115 - $9,537	3,300 Added 4.09%	84,061 $134,000
Q3 2019 Nov 13, 2019	BUY	$2.41 - $3.05 $14,701 - $18,605	6,100 Added 8.17%	80,761 $229,000
Q2 2019 Aug 12, 2019	BUY	$2.45 - $3.5 $18,375 - $26,250	7,500 Added 11.17%	74,661 $224,000
Q1 2019 May 14, 2019	BUY	$2.09 - $4.45 $23,226 - $49,452	11,113 Added 19.83%	67,161 $205,000
Q4 2018 Feb 13, 2019	BUY	$1.61 - $4.0 $90,237 - $224,192	56,048 New	56,048 $90,000

Others Institutions Holding XTNT

# of Institutions

Shares Held

98.2M

Call Options Held

Put Options Held

View Full List

About Xtant Medical Holdings, Inc.

Ticker XTNT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 108,226,000
Market Cap $40M
Description
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...

More about XTNT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account